Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Anemia”

702 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 702 results

Large-scale testing (Phase 3)WithdrawnNCT00384657
What this trial is testing

Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseChronic Heart FailureAnemia
Anemia Working Group Romania
Large-scale testing (Phase 3)Ended earlyNCT00004465
What this trial is testing

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Who this might be right for
Hemolytic Uremic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 145
Not applicableEnded earlyNCT00663507
What this trial is testing

Kidney Transplantation in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 2
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Not applicableNot Yet RecruitingNCT06521216
What this trial is testing

Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

Who this might be right for
CKD
Assiut University 150
Not applicableEnded earlyNCT01290328
What this trial is testing

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

Who this might be right for
Anemia
Mehrotra, Anita, M.D. 100
Large-scale testing (Phase 3)Study completedNCT01628107
What this trial is testing

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Who this might be right for
Chronic Renal Failure Requiring Hemodialysis
Pfizer 406
Large-scale testing (Phase 3)Not Yet RecruitingNCT07300111
What this trial is testing

Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

Who this might be right for
Anaemia
Qilu Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT02912533
What this trial is testing

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Anemia
Kissei Pharmaceutical Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT00204334
What this trial is testing

Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationAnemia
University Hospital Muenster 60
Not applicableStudy completedNCT02136563
What this trial is testing

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

Who this might be right for
Renal AnemiaChronic Kidney Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069533
What this trial is testing

Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

Who this might be right for
Fanconi Anemia Complementation Group A
Rocket Pharmaceuticals Inc. 7
Testing effectiveness (Phase 2)Study completedNCT03054337
What this trial is testing

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
AnemiaNon-dialysis Dependent Chronic Kidney Disease
Akebia Therapeutics 51
Not applicableStudy completedNCT01902628
What this trial is testing

OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 437
Testing effectiveness (Phase 2)Study completedNCT00048035
What this trial is testing

Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 91
Large-scale testing (Phase 3)Study completedNCT00317226
What this trial is testing

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Who this might be right for
Anemia
American Regent, Inc. 145
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175051
What this trial is testing

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Who this might be right for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Albuminuria
University of Illinois at Chicago 20
Not applicableUnknownNCT03605511
What this trial is testing

TTP and aHUS in Complicated Pregnancies

Who this might be right for
Thrombotic Thrombocytopenic PurpuraAtypical Hemolytic Uremic SyndromePre-Eclampsia+5 more
University College, London 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04889430
What this trial is testing

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 34
Load More Results